The U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 23 (VISN 23), has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the delivery of test kit reagents and associated diagnostic platforms. This single-award BPA, with a total ceiling value of $14,732,632.16, is part of Biomerieux's existing Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. The contract, which does not have a set-aside designation, has a period of performance through November 30, 2028 and will support the VA's clinical laboratory operations and healthcare facilities across VISN 23. Biomerieux, through its Biomerieux, Inc. division, will provide a range of its proprietary diagnostic equipment, such as the BioFire FilmArray system and VITEK analyzers, as well as associated reagents and consumables to enable rapid pathogen detection and identification for infectious disease testing.
The task orders issued under this BPA have ceiling values ranging from $42,167.60 to $930,018.60, with firm-fixed-price delivery orders for the supply of test kit reagents to VISN 23 locations. As the sole-source provider for its specialized diagnostic technologies, Biomerieux's products and services are critical in supporting the VA's healthcare operations and ensuring a reliable supply of essential in vitro diagnostic solutions.
Generated 2/8/25, 9:02 AM